Payer PolicyActive
Antiprothrombin Antibody Testing
AETNA-CPB-0662
Aetna
Effective: September 14, 2023
Updated: December 6, 2025
created · Dec 2, 2025
Policy Summary
Aetna considers antiprothrombin antibody testing experimental and investigational and does not cover it (including for ICD‑10 codes D68.61, N96, and O26.20–O26.23). Key requirement: none—testing is only supported in research because its clinical value, reproducibility, and impact on diagnosis/management have not been established.
Coverage Criteria Preview
Key requirements from the full policy
"None — Aetna considers antiprothrombin antibody testing experimental and investigational because its clinical value has not been established."
Sign up to see full coverage criteria, indications, and limitations.